"Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Descriptor ID |
D009369
|
| MeSH Number(s) |
C04
|
| Concept/Terms |
Neoplasms- Neoplasms
- Neoplasia
- Neoplasias
- Neoplasm
- Tumors
- Tumor
Cancer- Cancer
- Cancers
- Malignant Neoplasms
- Malignant Neoplasm
- Neoplasm, Malignant
- Neoplasms, Malignant
- Malignancy
- Malignancies
Benign Neoplasms- Benign Neoplasms
- Neoplasms, Benign
- Benign Neoplasm
- Neoplasm, Benign
|
Below are MeSH descriptors whose meaning is more general than "Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Neoplasms".
This graph shows the total number of publications written about "Neoplasms" by people in this website by year, and whether "Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 7 | 1 | 8 |
| 2004 | 10 | 3 | 13 |
| 2005 | 7 | 2 | 9 |
| 2006 | 7 | 2 | 9 |
| 2007 | 12 | 2 | 14 |
| 2008 | 10 | 0 | 10 |
| 2009 | 11 | 3 | 14 |
| 2010 | 19 | 5 | 24 |
| 2011 | 14 | 4 | 18 |
| 2012 | 15 | 6 | 21 |
| 2013 | 19 | 4 | 23 |
| 2014 | 17 | 2 | 19 |
| 2015 | 24 | 1 | 25 |
| 2016 | 36 | 2 | 38 |
| 2017 | 31 | 2 | 33 |
| 2018 | 28 | 4 | 32 |
| 2019 | 36 | 8 | 44 |
| 2020 | 49 | 3 | 52 |
| 2021 | 53 | 3 | 56 |
| 2022 | 43 | 2 | 45 |
| 2023 | 27 | 0 | 27 |
| 2024 | 22 | 10 | 32 |
| 2025 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasms" by people in Profiles.
-
National survey of financial burden and experience among patients with cancer and autoimmune disease receiving charitable copay assistance. Cancer. 2025 Jan 15; 131(2):e35721.
-
Screening for Financial Toxicity in Oncology Research and Practice: A Narrative Review. JCO Oncol Pract. 2025 Jan; 21(1):5-11.
-
Financial Toxicity in Older Adults With Cancer and Their Caregivers. JCO Oncol Pract. 2025 Jan; 21(1):92-99.
-
Cost Conversations to Mitigate the Effects of Financial Toxicity in Oncology: Current State, Opportunities, and Barriers. JCO Oncol Pract. 2025 Jan; 21(1):23-28.
-
Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U. JCO Precis Oncol. 2024 Dec; 8:e2400327.
-
Real-time viscoelastic deformability cytometry: High-throughput mechanical phenotyping of liquid and solid biopsies. Sci Adv. 2024 Dec 06; 10(49):eabj1133.
-
Symptom trajectories over time by cannabis use status among patients undergoing cancer treatment. Sci Rep. 2024 11 16; 14(1):28319.
-
Pilot implementation and qualitative evaluation of a financial hardship screening among Native American patients with cancer. Support Care Cancer. 2024 Nov 15; 32(12):792.
-
Serious Games for Serious Pain: Development and Initial Testing of a Cognitive Behavioral Therapy Game for Patients With Advanced Cancer Pain. JCO Clin Cancer Inform. 2024 Nov; 8:e2400111.
-
Three-Dimensional In Vitro Cell Cultures as a Feasible and Promising Alternative to Two-Dimensional and Animal Models in Cancer Research. Int J Biol Sci. 2024; 20(13):5293-5311.